False-negative
18
F-PSMA-1007 PET/CT in metastatic prostate cancer related to high physiologic liver uptake
Eur J Nucl Med Mol Imaging
.
2020 Jul;47(8):2044-2046.
doi: 10.1007/s00259-019-04645-5.
Epub 2019 Dec 27.
Authors
Philipp E Hartrampf
1
,
Anna Katharina Seitz
2
,
Markus Krebs
2
3
,
Andreas K Buck
1
,
Constantin Lapa
4
5
Affiliations
1
Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany.
2
Department of Urology and Paediatric Urology, University Hospital Würzburg, Würzburg, Germany.
3
Comprehensive Cancer Center Mainfranken, University Hospital Würzburg, Würzburg, Germany.
4
Department of Nuclear Medicine, University Hospital Würzburg, Würzburg, Germany. lapa_C@ukw.de.
5
Department of Nuclear Medicine, University Hospital Augsburg, Augsburg, Germany. lapa_C@ukw.de.
PMID:
31879815
DOI:
10.1007/s00259-019-04645-5
No abstract available
Publication types
Case Reports
MeSH terms
Aged
Humans
Liver
Male
Niacinamide / analogs & derivatives
Oligopeptides
Positron Emission Tomography Computed Tomography*
Prostatic Neoplasms* / diagnostic imaging
Substances
Oligopeptides
PSMA-1007
Niacinamide